Diazyme Laboratories, Inc.

Diazyme Laboratories, Inc. Diazyme is a clinical chemistry reagent manufacturer that develops IVD assays for use on conventional open channel automated chemistry platforms.

Understanding Lp-PLA₂ & Cardiovascular RiskCardiovascular disease remains a leading cause of mortality worldwide, often ...
06/04/2026

Understanding Lp-PLA₂ & Cardiovascular Risk

Cardiovascular disease remains a leading cause of mortality worldwide, often developing silently until a major event occurs. That’s where early risk assessment plays a crucial role.

Diazyme’s PLAC® Assay measures Lp-PLA₂, a key biomarker associated with vascular inflammation and increased cardiovascular risk. By detecting elevated levels of Lp-PLA₂, clinicians can identify at-risk patients earlier and take proactive steps toward prevention.

Stay ahead of cardiovascular disease with innovative diagnostics. Learn more about the PLAC® Assay and its impact on heart health.

Get a quote today! https://bit.ly/4wU474t

World Heart Rhythm Week | Raising Awareness, Improving OutcomesHeart rhythm disorders, such as atrial fibrillation and a...
06/01/2026

World Heart Rhythm Week | Raising Awareness, Improving Outcomes

Heart rhythm disorders, such as atrial fibrillation and arrhythmias, affect millions worldwide and often go undetected until serious complications arise.

At Diazyme, we’re committed to supporting early detection and ongoing management through our innovative cardio testing solutions. From risk assessment to routine monitoring, our assays empower healthcare providers with the tools they need to deliver faster, more accurate diagnoses.

This week, we join the global effort to raise awareness of heart rhythm conditions and advocate for better access to cardiovascular diagnostics.

Explore Diazyme’s full menu of cardiovascular markers:
https://bit.ly/4dRf79P

Diazyme Laboratories, Inc. is pleased to announce the acquisition of the business of Carolina Liquid Chemistries Corpora...
06/01/2026

Diazyme Laboratories, Inc. is pleased to announce the acquisition of the business of Carolina Liquid Chemistries Corporation (CLC), an FDA-registered manufacturer and value-added reseller of chemistry systems and reagents based in Greensboro, North Carolina.

CLC’s cost-effective and reliable product portfolio will be integrated into Diazyme’s operations, complementing our proprietary enzyme and immunoassay technologies. This strategic acquisition strengthens our ability to deliver comprehensive diagnostic solutions to reference and clinical laboratories of all sizes, supporting improved patient outcomes.

Read full press release - http://bit.ly/4e1kFPl

May is Blood Pressure Awareness Month – and it’s more than just knowing your numbers.While blood pressure cuffs tell us ...
05/20/2026

May is Blood Pressure Awareness Month – and it’s more than just knowing your numbers.

While blood pressure cuffs tell us how hard the heart is working, a deeper look at vascular biomarkers can reveal the why and help predict what’s next.

Here are three powerful biomarkers helping clinicians go beyond the basics:

✅ Homocysteine – Elevated levels can damage blood vessels, promote arterial stiffness, and contribute to rising blood pressure, especially in those with vitamin B deficiencies.

✅ hs-CRP – A sensitive marker of systemic inflammation. Chronic inflammation can worsen hypertension and signal a higher risk of heart disease.

✅ PLAC® (Lp-PLA2) – A specific indicator of vascular inflammation and plaque vulnerability. Particularly useful in patients with high blood pressure and hidden cardiovascular risk.

Understanding these markers offers a clearer picture of a patient’s cardiovascular health, beyond just systolic and diastolic values.

💡 Early detection = early intervention.

This month, let’s raise awareness not just for blood pressure itself, but for the underlying factors that silently drive it.

Learn more here: https://bit.ly/4t1PA3A

May is Stroke Awareness Month – a time to shine a light on one of the leading causes of death and disability worldwide.A...
05/12/2026

May is Stroke Awareness Month – a time to shine a light on one of the leading causes of death and disability worldwide.

At Diazyme, we’re proud to support stroke prevention with our PLAC® Activity Test, the only FDA-cleared assay that measures Lp-PLA2 activity—an enzyme associated with vascular inflammation and increased risk of ischemic stroke.

Early detection can save lives. By identifying at-risk patients before an event occurs, the PLAC® Activity Test empowers healthcare providers to take proactive steps toward prevention.

Let’s work together to raise awareness, support early risk assessment, and ultimately reduce the burden of stroke in our communities.

🔬 Learn more about the PLAC® Activity Test: https://bit.ly/41YFh5e

May is Lung Health Awareness Month — a reminder of the importance of early research and innovation in the fight against ...
05/01/2026

May is Lung Health Awareness Month — a reminder of the importance of early research and innovation in the fight against chronic respiratory diseases.

At Diazyme, we're proud to support the scientific community with tools that advance research into lung health. Our DZ-Lite™ MMP-1 and MMP-7 CLIA Kits are designed for the quantitative detection of matrix metalloproteinases, enzymes involved in tissue remodeling and inflammation often seen in chronic lung conditions such as COPD, IPF, and other interstitial lung diseases.

🔬 These assays are for research use only, supporting the development of new insights and potential breakthroughs in understanding lung disease progression and pathophysiology.

Learn more about Diazyme’s lung disease marker solutions:
🔗 https://bit.ly/48VFKJ8

The future of biomarker diagnostics: Diazyme’s commitment to advancing lab medicine. At Diazyme, we’re focused on shapin...
04/28/2026

The future of biomarker diagnostics: Diazyme’s commitment to advancing lab medicine.

At Diazyme, we’re focused on shaping the future of biomarker diagnostics with cutting-edge solutions that help healthcare providers detect, diagnose, and manage diseases more effectively. Our commitment to innovation is driving the development of next-generation assays that enhance accuracy, streamline workflows, and improve patient outcomes.

As we look ahead, we remain dedicated to advancing lab medicine and providing the tools necessary for better, more proactive healthcare.

The future of diagnostics is here—and we’re proud to be at the forefront of it.

Discover how we’re driving lab innovation: https://bit.ly/36lKaaV

The Diazyme Total Bile Acids Assay provides laboratories with a reliable and efficient solution for quantitative bile ac...
04/22/2026

The Diazyme Total Bile Acids Assay provides laboratories with a reliable and efficient solution for quantitative bile acid measurement in serum. With liquid stable reagents and results in as little as 8 minutes, laboratories can streamline testing while maintaining dependable performance.

Key advantages include:
✔ Minimal interference from triglycerides, bilirubin, and hemolysis
✔ Results in as little as 8 minutes
✔ Liquid stable reagents
✔ Flexible instrument parameters to support simplified implementation

Learn more about the assay and how it supports clinical laboratories:
🔗 https://bit.ly/4lRG3Ko

Supporting Liver Health on World Liver DayThe liver plays a vital role in overall health, yet liver diseases often go un...
04/19/2026

Supporting Liver Health on World Liver Day

The liver plays a vital role in overall health, yet liver diseases often go undiagnosed until they reach advanced stages. At Diazyme, we’re committed to improving liver health diagnostics with innovative assays like the Total Bile Acid (TBA) assay and Adenosine Deaminase (ADA) assay, which are critical for the early detection and monitoring of liver function.

These advanced solutions equip healthcare professionals with the tools they need for accurate diagnoses and better patient outcomes.

This World Liver Day, let’s raise awareness about the importance of liver health and the role of diagnostics in prevention and early intervention.

Take a closer look at our complete Liver Health Panel: https://bit.ly/3N2sBms

Address

12889 Gregg Court
Poway, CA
92064

Website

Alerts

Be the first to know and let us send you an email when Diazyme Laboratories, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category